James Rawls

James Rawls

Vice President, Head of Global Regulatory Affairs, and Chair, Diversity, and Inclusion Council
Sunovion Pharmaceuticals Inc.

James Rawls is a 25-year veteran of the pharmaceutical industry who has successfully led the global drug registration of innovative products across a variety of therapeutic areas in the United States, Europe and Japan. James is Vice President, Head of Global Regulatory Affairs at Sunovion Pharmaceuticals and under his leadership the department has successfully worked with cross-functional teams to advance the development, registration, and commercialization of innovative new treatments for serious Central Nervous System (CNS) and respiratory conditions to help patients. James serves as Chair of the organization’s Diversity & Inclusion Council. He has led efforts to operationalize a multi-year diversity and inclusion strategy to create a more diverse and inclusive organization. James completed a post-doctoral fellowship at Rutgers University and Novartis Pharmaceuticals and holds a Doctor of Pharmacy degree, Pharm.D., from the University of Michigan.